Search Results

Thailand Advances SMR Regulatory and Public Engagement Preparations, Plans to Commission First Unit by 2037

From September 9 to 11, 2026, the U.S. Department of State held the FIRST and Thailand Stakeholder Engagement Workshop in Bangkok. The workshop was co-hosted by the Thailand Institute of Nuclear Technology (TINT) and the Electricity Generating Authority of Thailand (EGAT), aiming to support Thailand's preliminary preparations for small modular reactors (SMRs), with a focus on transparent communication, public trust, and stakeholder engagement. The FIRST program, whose full name is Foundational Infrastructure for the Responsible Use of Small Modular Reactor Technology, was initiated by the U.S. Department of State and mainly supports relevant countries in...

2026-09-12

South Korea Conducts First Joint Radiation Emergency Exercise Involving Two Nuclear Power Plants Simultaneously

The Nuclear Safety and Security Commission (NSSC) of South Korea announced on September 10 that South Korea held the 2026 National Joint Radiation Disaster Prevention Exercise, simulating a radioactive material release accident at the Wolsong Nuclear Power Plant in Gyeongju, North Gyeongsang Province, and the simultaneous entry into a radiation emergency state at the Hanul Nuclear Power Plant in Uljin County, North Gyeongsang Province. Approximately 2,000 people participated in the exercise, including relevant South Korean central government departments, local governments, specialized agencies, relevant operating organizations, local organizations, and nearby residents. This exercise set up a compound disaster scenario of simultaneous radiation emergencies at multiple nuclear power plants for the first time. The exercise assumed that...

2026-09-12

First Supercapacitor Pulsed Power Supply System of the HL-3 Upgrade Project Successfully Handed Over

On September 10, the 300MVA/3000MJ supercapacitor pulsed power supply system of the HL-3 upgrade project was successfully handed over. This is the first system of the project to complete handover, marking that the project construction is gradually transitioning from the equipment installation and subsystem static commissioning stage to the system joint commissioning stage, providing support for advancing fusion engineering. Zhang Libo, President and Deputy Secretary of the Party Committee of the Southwestern Institute of Physics, and Chen Qingchuan, Vice President, attended the handover ceremony. Zhang Libo stated at the ceremony that the completion of the handover of the first system is the result of collaborative efforts by all participating units, accumulating experience and creating conditions for subsequent system joint commissioning. All parties will continue to consolidate responsibilities and advance key milestones on schedule....

2026-09-12

Canada Supports IAEA "Rays of Hope" Initiative for the First Time, Will Provide Medical Isotope Training for Latin America

The Canadian Nuclear Isotope Council (CNIC) announced on September 10 that Canada has for the first time formally provided support to the International Atomic Energy Agency (IAEA) Rays of Hope initiative, and will help enhance cancer diagnosis and treatment capacity in Latin America through training in the production of medical radioisotopes and radiopharmaceuticals. The Rays of Hope initiative aims to expand access to cancer treatment and radiotherapy infrastructure in low- and middle-income countries. Under the arrangement, from November 8 to 14, 26 relevant sector leaders from Argentina, Brazil, Chile and Mexico will travel to Ontario, Canada, to participate in a training program jointly organized by Bruce Power and McMaster University. The training will focus on medical isotopes...

2026-09-11

India's Fortis Healthcare Plans to Introduce the Country's First Upright Proton Therapy System

India's Fortis Healthcare has announced plans to install Mevion Medical Systems' MEVION S250-FIT proton therapy system at Fortis Memorial Research Institute (FMRI) in Gurugram. The hospital is Fortis' flagship quaternary care hospital and its comprehensive oncology and precision cancer treatment center. According to reports, the system will be equipped with Leo Cancer Care's Marie® upright patient positioning and imaging solution, as well as RaySearch Laboratories' RayStation® treatment planning software. If the project receives relevant regulatory approvals and completes site preparation, Fortis will become India's first planned...

2026-09-10

First concrete poured for turbine building foundation of Unit 3 VVER-1200 at Leningrad NPP Phase II

On September 9, 2026, concrete pouring began for the foundation of the turbine building of Unit 3 VVER-1200 at Leningrad NPP Phase II in Russia. Construction workers have completed the pouring of the central section of the future foundation, with concrete consumption approaching 5,000 cubic meters. This pour is the first stage of construction of the foundation structure for this building. According to the plan, the contractor will use nearly 5,000 tonnes of rebar and more than 20,000 cubic meters of high-strength concrete to build a monolithic foundation slab 2.5 meters high and more than 8,000 square meters in area. The related operations are currently being carried out simultaneously in 7 construction zones. Konstantin Khudyakov, head of the Leningrad NPP project at TITAN-2 Holding (TITAN-2), said that the foundation construction of the turbine building places high demands on concrete quality, pouring technology and curing conditions, especially in the first few days after pouring, when it is necessary to focus on controlling on-site temperature and humidity and preventing mechanical damage. After the concrete reaches design strength, the contractor will, together with the owner, use non-destructive testing methods to inspect the structure, including ultrasonic testing; at the same time, specimens made from the same batch of concrete will also be subjected to compressive tests on a hydraulic press to confirm that the foundation is capable of bearing the loads of walls, floors, piping and large operating equipment.

2026-09-10

U.S. Plans to Deploy Navy's First Shore-Based Advanced Microreactor in Indiana by 2028

The U.S. Department of Defense (DoD) announced on September 9, 2026, that it plans to install an advanced nuclear Micro Modular Reactor (MMR) at Naval Weapons Station Crane (NWS Crane) in Indiana no later than September 2028. This is Indiana's first nuclear reactor project for power generation and an early project of the U.S. Department of Defense to advance advanced nuclear energy deployment at military installations. According to the announcement, the project is jointly advanced by the U.S. Army's Janus Program, the Office of the Assistant Secretary of the Navy for Energy, Installations, and Environment, the Office of the Under Secretary of Defense for Research and Engineering, and Indiana...

2026-09-10

Construction of Vietnam's first nuclear power plant will boost Russia-Vietnam scientific and technological cooperation

On September 9, Russian Deputy Prime Minister Dmitry Chernyshenko said at the Russia-Vietnam Science and Technology Forum that the construction of Vietnam's first nuclear power plant will strongly promote cooperation between Russia and Vietnam in science and high technology. Russian Deputy Prime Minister Dmitry Chernyshenko Chernyshenko noted that many Russian universities are cultivating engineering and technical talent for Vietnam's economic development. In March this year, Russia and Vietnam signed an intergovernmental agreement on the construction of Vietnam's first nuclear power plant. He said the project will provide important support for cooperation in related fields, high-tech industries, and basic and applied scientific research. According to earlier information, Russia and Vietnam on March 23...

2026-09-10

South Korea's First Animal Radiopharmaceutical Approved for the Treatment of Feline Hyperthyroidism

The Korea Atomic Energy Research Institute announced on September 10 that Thyrokitty Injection (I-131), a radiopharmaceutical for the treatment of feline hyperthyroidism developed by the research team led by Dr. Lim Jae-cheong, has obtained an animal drug manufacturing license issued by the Animal and Plant Quarantine Agency of South Korea. This is South Korea's first animal radiopharmaceutical to receive final product approval, marking the transition of related technologies that had previously been mainly at the R&D stage into clinical therapeutic application for pets. Feline hyperthyroidism is a relatively common endocrine disease in older cats, mainly characterized by excessive secretion of thyroid hormones. According to reports, approximately 10% of cats aged 10 and above may suffer from this disease. Traditional treatment methods typically require...

2026-09-10

Australia's First ZAP-X Gyroscopic Radiosurgery Platform to Be Installed at St Vincent's Hospital Sydney

ZAP Surgical Systems has announced that GenesisCare will become the first cancer treatment provider in Australia to introduce the ZAP-X Gyroscopic Radiosurgery® platform. The device is expected to be installed this month at GenesisCare's center at St Vincent's Hospital in Sydney, New South Wales, with the first patients anticipated to begin treatment before the end of the year. The deployment of the ZAP-X platform will enhance GenesisCare's neuro-oncology treatment capabilities in Sydney, enabling it to deliver dedicated stereotactic radiosurgery (SRS). Previously, SRS patients were primarily treated using cobalt-60 systems and multi-purpose radiotherapy linear accelerators. The ZAP-X, in contrast, is a dedicated platform designed for non-inv...

2026-09-09

Alpha-9 Oncology Initiates Phase 1 Clinical Trial of GRPR-Targeted Radiotherapy, First Patient Dosed

Alpha-9 Oncology, a U.S. clinical-stage radiopharmaceutical company, recently announced that the first patient has been dosed in its Phase 1 clinical trial evaluating two GRPR-targeted radiopharmaceuticals. The study involves the actinium-225-labeled compound 225Ac-A9-0642 and the lutetium-177-labeled compound 177Lu-A9-0631, primarily enrolling patients with breast cancer and other solid tumors, with data expected to be released by the end of 2027. According to the company, both 225Ac-A9-0642 and 177Lu-A9-0631 target the gastrin-releasing peptide receptor (GRPR). GRPR is considered a solid tumor-associated target with potential clinical value in breast cancer and other solid tumors. 225Ac-A9-0642 is Alpha-9's first actinium-225 GRPR-targeted compound to enter clinical evaluation...

2026-09-09

BESIII Experiment Achieves High-Precision Measurement of Charm Meson Semileptonic Decays and First Constraint on "Scalar Current"

Recently, the BESIII international collaboration utilized the world's largest near-threshold charm meson data sample to perform a combined measurement of four semileptonic decay channels: D⁰→K⁻e⁺νₑ, D⁰→K⁻μ⁺νμ, D⁺→K̄⁰e⁺νₑ, and D⁺→K̄⁰μ⁺νμ. The research team extracted the quark mixing matrix element |Vcs| with a precision better than 0.5%, determined the form factor zero-point value f₊(0) with a precision better than 0.2%, and verified lepton universality in the above processes at the 0.5% precision level. Beyond these precise determinations of Standard Model parameters, what is particularly noteworthy is that this experiment has, for the first time...

2026-09-08

South Korea's DuChemBio to Build Country's First Radiopharmaceutical CDMO Plant

South Korean radiopharmaceutical therapy company DuChemBio will build the country's first contract development and manufacturing organization (CDMO) plant dedicated to radiopharmaceuticals, in response to growing demand for radiopharmaceuticals used in the diagnosis and treatment of cancer and neurological diseases. DuChemBio is a subsidiary of healthcare distributor Geo-Young Group. The company recently signed an investment agreement with North Jeolla Province and the city of Jeongeup to invest KRW 34.3 billion (approximately USD 25.5 million) in building a new plant in Jeongeup. The company stated that this is the largest investment since Geo-Young acquired DuChemBio. According to the plan, the new facility will integrate radioisotope production...

2026-09-08

US Kairos Completes First Phase Testing of ETU 3 Reactor Model

Kairos Power announced on September 7 that its Engineering Test Unit 3 (ETU 3) has completed the first phase of testing. The testing, centered on the Hermes 2 reactor cavity model, validated the precast concrete shielding design as well as remote operation and maintenance capabilities, providing support for the design of the Hermes 2 demonstration plant and subsequent commercial units. Reactor cavity model (Image: Kairos Power) ETU 3, located in Oak Ridge, Tennessee, is part of Kairos Power's iterative development program for its fluoride salt-cooled high-temperature reactor (KP-FHR) technology. The unit is a scaled, non-nuclear mockup cavity consisting of a reactor pressure vessel and precast concrete shielding structures.

2026-09-08

UK's First TerraPower Natrium Reactor Could Generate Power by 2034

TerraPower, the US nuclear power company backed by Bill Gates, expects its Natrium sodium-cooled reactor could generate electricity in the UK as early as 2034. If the project progresses smoothly, the UK will become the company's first market for deploying this technology outside the United States. TerraPower CEO Chris Levesque said that given the company's first Natrium reactor project is scheduled for completion in 2031, the Natrium technology is highly likely to become a reality in the UK by 2034. The technology has already met relevant US regulatory requirements, and the first unit is under construction in Wyoming. In recent years, the UK has accelerated the development of small modular re...

2026-09-08